Biological activities of venoms from South American snakes.
Standard assay procedures for the characterization of snake venoms, developed by the World Health Organization (WHO) Collaborating Centre for the Control of Antivenoms (CCCA), were used to analyse 33 snake venoms including eight International Reference Venoms for the assessment of lethal, defibrinogenating, procoagulant, haemorrhagic and necrotizing properties. The International Reference Venoms were assayed as part of an International Collaborative Programme for the evaluation of Venoms and Antivenoms; the results showed a close relationship to those obtained by the CCCA. Twenty-five venoms from 13 different species of medically important snakes from South America were assayed as standardized by the WHO-CCCA. Additionally, evaluation of lethal activity by the i.p. and intra cerebroventricular routes, proteolytic effects and venom-induced edema were also determined. Venom yields from captive snakes are also presented. Among the venoms examined, from the subfamily Crotalinae, the members of the genera Bothrops and Lachesis had strong haemorrhagic, proteolytic and edema-inducing activities, whereas all Crotalus durissus species had none. The Elapinae, Micrurus frontalis showed no procoagulant, defibrinogenating, haemorrhagic, necrotizing or proteolytic activities. The results reflect differences among individual samples of the same species and of different geographical regions. The results suggest that there is little or no relationship between the properties of the different venoms and that the determination of one effect cannot predict the value of the others. Therefore, the characterization of the different activities of snake venoms is necessary if toxicity is to be properly evaluated and neutralized.
Sanchez
E F
EF
Fundação Ezequiel Dias, Centro de Pesquisa e Desenvolvimento, Belo Horizonte (MG), Brazil.
Freitas
T V
TV
Ferreira-Alves
D L
DL
Velarde
D T
DT
Diniz
M R
MR
Cordeiro
M N
MN
Agostini-Cotta
G
G
Diniz
C R
CR
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002364:Caseins / Q000378:metabolism; D004487:Edema / Q000139:chemically induced; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011897:Random Allocation; D015203:Reproducibility of Results; D012910:Snake Venoms / Q000633:toxicity*; D013020:South America; D014116:Toxicology / Q000592:standards*
D002364:Caseins; D012910:Snake Venoms